SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001161697-19-000021
Filing Date
2019-01-07
Accepted
2019-01-07 16:11:39
Documents
38
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT NO. 1 TO QUARTERLY REPORT FOR 10-31-2018 form_10-q.htm 10-Q/A 16303
  Complete submission text file 0001161697-19-000021.txt   1500925

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE ntrr-20181031.xml EX-101.INS 287530
3 XBRL SCHEMA FILE ntrr-20181031.xsd EX-101.SCH 23485
4 XBRL CALCULATION FILE ntrr-20181031_cal.xml EX-101.CAL 25754
5 XBRL DEFINITION FILE ntrr-20181031_def.xml EX-101.DEF 77033
6 XBRL LABEL FILE ntrr-20181031_lab.xml EX-101.LAB 156895
7 XBRL PRESENTATION FILE ntrr-20181031_pre.xml EX-101.PRE 129313
Mailing Address 54 SUGAR CREEK CENTER BLVD. SUITE 200 SUGAR LAND TX 77478
Business Address 54 SUGAR CREEK CENTER BLVD. SUITE 200 SUGAR LAND TX 77478 (702) 793-4121
NEUTRA CORP. (Filer) CIK: 0001512886 (see all company filings)

IRS No.: 274505461 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q/A | Act: 34 | File No.: 000-55077 | Film No.: 19513451
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences